Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
An Interview With Franco Negron
Simtra’s capability to support high-volume injectables and lower-volume modalities provides balanced expertise across the sterile injectables landscape. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more
We Have More Data Than We Know What to Do With
Every year brings another round of headlines about pharma “drowning in data.” At this point, that’s less a warning than a permanent weather condition. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

NanoImaging Services, Proteos Combine as TrueCourse Biosciences; Gottler Named CEO
Tuesday, September 22, 2026
NanoImaging Services and Proteos have combined under the name TrueCourse Biosciences, creating a U.S.-based contract research organization focused on ... read more
Kincell Bio, Cellipont Bioservices Merge to Form Kincellis Advanced Therapies
Tuesday, September 22, 2026
Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies, a U.S.-based contract development and ... read more
Gaelic and Athlone to Launch Dual-Source Antibiotic Supply Strategy
Monday, September 21, 2026
Gaelic Laboratories and Athlone Laboratories have aligned their manufacturing processes to offer customers a dual-source supply of oral beta-lactam ... read more
mAbxience, Sandoz Partner on Emicizumab Biosimilar for Hemophilia A
Monday, September 21, 2026
mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed biosimilar version of ... read more
Made Scientific Buys 85,000-Square-Foot Pennsylvania Cell-Therapy Plant
Monday, September 21, 2026
Made Scientific has acquired an 85,000-square-foot cell-therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience, ... read more